Over the past three decades, clinical trials have demonstrated that restoring beta-cell function through islet or pancreas transplantation can lead to more physiologic regulation of blood sugar levels compared to exogenous insulin in diabetes patients (58). The gene discussed is INS; the disease is diabetes mellitus.